{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:53:41Z","timestamp":1781636021854,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,16]]},"DOI":"10.7759\/cureus.110978","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:05:17Z","timestamp":1781633117000},"source":"Crossref","is-referenced-by-count":0,"title":["A Systematic Review and Meta-Analysis of Clinical Effectiveness of Intravenous Magnesium Sulphate in the Treatment of Acute Fast Atrial Fibrillation in Non-surgical Adult Patients"],"prefix":"10.7759","author":[{"given":"Kelvin","family":"Mupunga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willmore","family":"Chandavengerwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durai Pardon","family":"Nyabadza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide Belinda","family":"Masungo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)","volume":"45","author":"Van Gelder IC","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, et al.. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2024, 45:3314-414. 10.1093\/eurheartj\/ehae176","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs446","article-title":"Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology\/European Heart Rhythm Association\/European Association of Cardiothoracic Surgeons, the American College of Cardiology Foundation\/American Heart Association\/Heart Rhythm Society, and the Canadian Cardiovascular Society","volume":"34","author":"Kirchhof P","year":"2013","unstructured":"Kirchhof P, Curtis AB, Skanes AC, Gillis AM, Samuel Wann L, John Camm A. Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology\/European Heart Rhythm Association\/European Association of Cardiothoracic Surgeons, the American College of Cardiology Foundation\/American Heart Association\/Heart Rhythm Society, and the Canadian Cardiovascular Society. Eur Heart J. 2013, 34:1471-4. 10.1093\/eurheartj\/ehs446","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000000869","article-title":"Management of atrial fibrillation with rapid ventricular response in the intensive care unit: a secondary analysis of electronic health record data","volume":"48","author":"Moskowitz A","year":"2017","unstructured":"Moskowitz A, Chen KP, Cooper AZ, Chahin A, Ghassemi MM, Celi LA. Management of atrial fibrillation with rapid ventricular response in the intensive care unit: a secondary analysis of electronic health record data. Shock. 2017, 48:436-40. 10.1097\/SHK.0000000000000869","journal-title":"Shock"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society","volume":"74","author":"January CT","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al.. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019, 74:104-32. 10.1016\/j.jacc.2019.01.011","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)90633-3","article-title":"Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation","volume":"60","author":"Lemery R","year":"1987","unstructured":"Lemery R, Brugada P, Cheriex E, Wellens HJ. Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation. Am J Cardiol. 1987, 60:1406-8. 10.1016\/0002-9149(87)90633-3","journal-title":"Am J Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.581837","article-title":"Revisiting antiarrhythmic drug therapy for atrial fibrillation: reviewing lessons learned and redefining therapeutic paradigms","volume":"11","author":"Geng M","year":"2020","unstructured":"Geng M, Lin A, Nguyen TP. Revisiting antiarrhythmic drug therapy for atrial fibrillation: reviewing lessons learned and redefining therapeutic paradigms. Front Pharmacol. 2020, 11:581837. 10.3389\/fphar.2020.581837","journal-title":"Front Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse DG","year":"2002","unstructured":"Wyse DG, Waldo AL, DiMarco JP, et al.. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002, 347:1825-33. 10.1056\/NEJMoa021328","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvw028","article-title":"Treating arrhythmias with adjunctive magnesium: identifying future research directions","volume":"3","author":"Baker WL","year":"2017","unstructured":"Baker WL. Treating arrhythmias with adjunctive magnesium: identifying future research directions. Eur Heart J Cardiovasc Pharmacother. 2017, 3:108-17. 10.1093\/ehjcvp\/pvw028","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/acem.13522","article-title":"Low-dose magnesium sulfate versus high dose in the early management of rapid atrial fibrillation: randomized controlled double-blind study (LOMAGHI study)","volume":"26","author":"Bouida W","year":"2019","unstructured":"Bouida W, Beltaief K, Msolli MA, et al.. Low-dose magnesium sulfate versus high dose in the early management of rapid atrial fibrillation: randomized controlled double-blind study (LOMAGHI study). Acad Emerg Med. 2019, 26:183-91. 10.1111\/acem.13522","journal-title":"Acad Emerg Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.116.004521","article-title":"Magnesium for atrial fibrillation, myth or magic?","volume":"9","author":"Kotecha D","year":"2016","unstructured":"Kotecha D. Magnesium for atrial fibrillation, myth or magic?. Circ Arrhythm Electrophysiol. 2016, 9:e004521. 10.1161\/CIRCEP.116.004521","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.111492","article-title":"Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta\u2010analysis","volume":"93","author":"Ho KM","year":"2007","unstructured":"Ho KM, Sheridan DJ, Paterson T. Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta\u2010analysis. BMJ Heart. 2007, 93:1433-40. 10.1136\/hrt.2006.111492","journal-title":"BMJ Heart"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2022.01.017","article-title":"Magnesium in the management of atrial fibrillation with rapid ventricular response","volume":"8","author":"Nogic J","year":"2022","unstructured":"Nogic J, MacPherson M, Aldridge E, et al.. Magnesium in the management of atrial fibrillation with rapid ventricular response. JACC Clin Electrophysiol. 2022, 8:800-2. 10.1016\/j.jacep.2022.01.017","journal-title":"JACC Clin Electrophysiol"},{"key":"ref13","article-title":"Magnesium sulfate: an adjunctive therapy in the first hour of management of rapid atrial fibrillation in the emergency department","volume":"99","author":"Zaouche K","year":"2021","unstructured":"Zaouche K, Mhadhbi H, Boubaker R, Baccouche R, Khattech I, Majed K. Magnesium sulfate: an adjunctive therapy in the first hour of management of rapid atrial fibrillation in the emergency department. Tunis Med. 2021, 99:225-31.","journal-title":"Tunis Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/acem.13720","article-title":"Hot off the press: low-dose magnesium sulfate versus high dose in the early management of rapid atrial fibrillation: randomized controlled double-blind study","volume":"26","author":"Heitz C","year":"2019","unstructured":"Heitz C, Morgenstern J, Bond C, Milne WK. Hot off the press: low-dose magnesium sulfate versus high dose in the early management of rapid atrial fibrillation: randomized controlled double-blind study. Acad Emerg Med. 2019, 26:1093-5. 10.1111\/acem.13720","journal-title":"Acad Emerg Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.01.057","article-title":"Meta-analysis of magnesium therapy for the acute management of rapid atrial fibrillation","volume":"99","author":"Onalan O","year":"2007","unstructured":"Onalan O, Crystal E, Daoulah A, Lau C, Crystal A, Lashevsky I. Meta-analysis of magnesium therapy for the acute management of rapid atrial fibrillation. Am J Cardiol. 2007, 99:1726-32. 10.1016\/j.amjcard.2007.01.057","journal-title":"Am J Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2005.03.036","article-title":"Impact of intravenous magnesium on post-cardiothoracic surgery atrial fibrillation and length of hospital stay: a meta-analysis","volume":"80","author":"Henyan NN","year":"2005","unstructured":"Henyan NN, Gillespie EL, White CM, Kluger J, Coleman CI. Impact of intravenous magnesium on post-cardiothoracic surgery atrial fibrillation and length of hospital stay: a meta-analysis. Ann Thorac Surg. 2005, 80:2402-6. 10.1016\/j.athoracsur.2005.03.036","journal-title":"Ann Thorac Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195527","article-title":"Intravenous magnesium sulfate reduces the need for antiarrhythmics during acute-onset atrial fibrillation in emergency and critical care","volume":"11","author":"Gilardi E","year":"2022","unstructured":"Gilardi E, Pomero F, Ravera E, et al.. Intravenous magnesium sulfate reduces the need for antiarrhythmics during acute-onset atrial fibrillation in emergency and critical care. J Clin Med. 2022, 11:5527. 10.3390\/jcm11195527","journal-title":"J Clin Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2021.06.001","article-title":"Intravenous magnesium in the management of rapid atrial fibrillation: a systematic review and meta-analysis","volume":"78","author":"Ramesh T","year":"2021","unstructured":"Ramesh T, Lee PYK, Mitta M, Allencherril J. Intravenous magnesium in the management of rapid atrial fibrillation: a systematic review and meta-analysis. J Cardiol. 2021, 78:375-81. 10.1016\/j.jjcc.2021.06.001","journal-title":"J Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0197-2456(99)00026-4","article-title":"Assessing the quality of randomized trials: reliability of the Jadad scale","volume":"20","author":"Clark HD","year":"1999","unstructured":"Clark HD, Wells GA, Hu\u00ebt C, McAlister FA, Salmi LR, Fergusson D, Laupacis A. Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials. 1999, 20:448-52. 10.1016\/s0197-2456(99)00026-4","journal-title":"Control Clin Trials"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JAC","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref22","article-title":"P1820. What about magnesium sulfate in atrial fibrillation with acute heart failure?","author":"Benhalla H","year":"2015","unstructured":"Benhalla H, Fennich N. P1820. What about magnesium sulfate in atrial fibrillation with acute heart failure?. European Journal of Heart Failure Volume 17: Abstracts of the Heart Failure 2015 and the 2nd World Congress on Acute Heart Failure, Seville, Spain, 23-26th May 2015. Wiley, New York, NY; 2015."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(94)90190-2","article-title":"Magnesium therapy in new-onset atrial fibrillation","volume":"73","author":"Brodsky MA","year":"1994","unstructured":"Brodsky MA, Orlov MV, Capparelli EV, Allen BJ, Iseri LT, Ginkel M, Orlov YS. Magnesium therapy in new-onset atrial fibrillation. Am J Cardiol. 1994, 73:1227-9. 10.1016\/0002-9149(94)90190-2","journal-title":"Am J Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2009.00360.x","article-title":"Magnesium sulfate versus placebo for paroxysmal atrial fibrillation: a randomized clinical trial","volume":"16","author":"Chu K","year":"2009","unstructured":"Chu K, Evans R, Emerson G, Greenslade J, Brown A. Magnesium sulfate versus placebo for paroxysmal atrial fibrillation: a randomized clinical trial. Acad Emerg Med. 2009, 16:295-300. 10.1111\/j.1553-2712.2009.00360.x","journal-title":"Acad Emerg Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2004.09.013","article-title":"A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation","volume":"45","author":"Davey MJ","year":"2005","unstructured":"Davey MJ, Teubner D. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation. Ann Emerg Med. 2005, 45:347-53. 10.1016\/j.annemergmed.2004.09.013","journal-title":"Ann Emerg Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2026.1996.tb00274.x","article-title":"The acute effects of magnesium in atrial fibrillation and flutter with a rapid ventricular rate","volume":"8","author":"Walker S","year":"1996","unstructured":"Walker S, Taylor J, Harrod R. The acute effects of magnesium in atrial fibrillation and flutter with a rapid ventricular rate. Emerg Med. 1996, 8:207-13. 10.1111\/j.1442-2026.1996.tb00274.x","journal-title":"Emerg Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/jce.15911","article-title":"Efficacy of intravenous magnesium for the management of non-post operative atrial fibrillation with rapid ventricular response: a systematic review and meta-analysis","volume":"34","author":"Enayati A","year":"2023","unstructured":"Enayati A, Gin JH, Sajeev JK, et al.. Efficacy of intravenous magnesium for the management of non-post operative atrial fibrillation with rapid ventricular response: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2023, 34:1286-95. 10.1111\/jce.15911","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4022\/jafib.2389","article-title":"The role of magnesium in the management of atrial fibrillation with rapid ventricular rate","volume":"13","author":"Bhatti H","year":"2020","unstructured":"Bhatti H, Mohmand B, Ojha N, P Carvounis C, L Carhart R. The role of magnesium in the management of atrial fibrillation with rapid ventricular rate. J Atr Fibrillation. 2020, 13:2389. 10.4022\/jafib.2389","journal-title":"J Atr Fibrillation"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/ael085","article-title":"Magnesium sulphate as a technique of hypotensive anaesthesia","volume":"96","author":"Elsharnouby NM","year":"2006","unstructured":"Elsharnouby NM, Elsharnouby MM. Magnesium sulphate as a technique of hypotensive anaesthesia. Br J Anaesth. 2006, 96:727-31. 10.1093\/bja\/ael085","journal-title":"Br J Anaesth"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January CT","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, et al.. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014, 64:e1-76. 10.1016\/j.jacc.2014.03.022","journal-title":"J Am Coll Cardiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.15420\/usc.2007.4.1.14","article-title":"Epidemiology and economic burden of atrial fibrillation","volume":"4","author":"Bajpai A","year":"2007","unstructured":"Bajpai A, Camm AJ, Savelieva I. Epidemiology and economic burden of atrial fibrillation. US Cardiol Rev. 2007, 4:14-7. 10.15420\/usc.2007.4.1.14","journal-title":"US Cardiol Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496766-a-systematic-review-and-meta-analysis-of-clinical-effectiveness-of-intravenous-magnesium-sulphate-in-the-treatment-of-acute-fast-atrial-fibrillation-in-non-surgical-adult-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:05:18Z","timestamp":1781633118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496766-a-systematic-review-and-meta-analysis-of-clinical-effectiveness-of-intravenous-magnesium-sulphate-in-the-treatment-of-acute-fast-atrial-fibrillation-in-non-surgical-adult-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.110978","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}